| P2093 | author name string | MR Hayden | |
| | WT Gibson | |
| P2860 | cites work | Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice | Q24804882 |
| | Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment | Q32041175 |
| | Mycophenolate mofetil reduces tissue damage and inflammation in an experimental model of colitis in rats | Q32059658 |
| | Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. | Q34516841 |
| | Lymphocyte-Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide Depletion | Q41698111 |
| | Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir. | Q42537406 |
| | Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts | Q42555924 |
| | Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days | Q43618101 |
| | Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models | Q43620667 |
| | Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice | Q43658790 |
| | Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice | Q43685012 |
| | Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis | Q43688347 |
| | Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis. | Q43741050 |
| | Effects of mycophenolate mofetil in the development of systemic lupus erythematosus in (NZBxNZW)F1 mice | Q43828514 |
| | Rapid failure of pig islet transplantation in non human primates | Q43989253 |
| | Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil. | Q44091857 |
| | Mycophenolate sodium: tolerability and efficacy in transplantation in the rat. | Q44103629 |
| | Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice | Q44114226 |
| | Inhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue | Q44216337 |
| | Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat. | Q44289407 |
| | Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB x NZW)F1 mice. | Q44397965 |
| | Treatment by mycophenolate mofetil of advanced graft vascular disease in non-human primate recipients of orthotopic aortic allografts | Q44482852 |
| | Tacrolimus and mycophenolate mofetil provide effective immunosuppression in rat laryngeal transplantation | Q44536059 |
| | Mycophenolate mofetil significantly reduces leukocyte graft infiltration after heterotopic cardiac transplantation in a rat model: comparative study with cyclosporine and FK 506 | Q44612737 |
| | A short course of mycophenolate immunosuppression inhibits rejection, but not tolerance, of rat liver allografts in association with inhibition of interleukin-4 and alloantibody responses | Q44632264 |
| | Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease | Q44663778 |
| | Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model | Q44711158 |
| | Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation | Q44940055 |
| | Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts | Q45069261 |
| | Reduction of ICAM-1 and LFA-1-positive leukocytes in the perivascular space of arteries under mycophenolate mofetil therapy reduces rat heart transplant vasculopathy | Q45193247 |
| | Mycophenolate mofetil is compatible with CD28/CD154 costimulatory blockade in preventing transplant rejection | Q46399173 |
| | Prolonged survival of rat hindlimb allografts following short-course FK506 and mycophenolate mofetil combination therapy | Q46478642 |
| | Inhibition of MD-1 expression by immunosuppressants or antisense oligodeoxynucleotides on skin allograft survival in mice | Q46512919 |
| | Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat. | Q46654165 |
| | Use of combination of low-dose cyclosporine and RS-61443 in a rat hindlimb model of composite tissue allotransplantation | Q46683132 |
| | 15-Deoxyspergualin and cyclophosphamide, but not mycophenolate mofetil, prolong survival and attenuate renal disease in a murine model of ANCA-associated crescentic nephritis | Q46686137 |
| | Modulation of intra-pulmonary TGF-beta expression by mycophenolate mofetil in lupus prone MRL/lpr mice | Q46714189 |
| | Mycophenolate mofetil reduces production of interferon-dependent major histocompatibility complex induction during allograft rejection, probably by limiting clonal expansion | Q47926348 |
| | Effect of mycophenolate mofetil on atherosclerosis in a rabbit model: initial histologic and immunohistochemical analyses | Q47940633 |
| | Triple immunosuppression reduces mononuclear cell infiltration and prolongs graft life in pig-to-newborn baboon cardiac xenotransplantation | Q48032732 |
| | ENHANCEMENT OF ALLOGRAFT SURVIVAL BY COMBINATION RS-61443 AND DUP-785 THERAPY | Q56335985 |
| | Myoblast transplantation in non-dystrophic dog | Q58109294 |
| P433 | issue | 11_suppl | |
| P304 | page(s) | 27-34 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Mycophenolate mofetil and animal models | |
| P478 | volume | 15 | |